Accenture Awarded Three-Year Contract by Italian Medicines Agency for Implementation and Maintenance of Medicines' Evaluation Systems in Italy
New AIFA integrated IT system to increase service efficiency
ROME--(BUSINESS WIRE)-- Accenture has been awarded a new contract to develop, build and maintain an integrated Medicine Evaluation System by the Italian Medicines Agency (AIFA) - the national authority responsible for approving new medicines.
Over the next three years, Accenture will provide AIFA with management consulting and IT services supporting all AIFA processes for administration and medical technology.
This project, which will implement innovative technical solutions for AIFA and strengthen relationships with its stakeholders (patients, civil society, institutions and pharmaceutical companies), confirms AIFA's commitment to innovation, positioning the Agency at the forefront of European medicine agencies.
"This contract reinforces our commitment to the Italian public sector and government and it underscores Accenture's deep knowledge of the healthcare industry," said Gianmario Pisanu, who leads Accenture's Health & Public Service business in Italy. "Accenture will use its broad industry skills and insights from our global network to support AIFA's mission to protect public health, provide greater access to innovative treatment and promote research and innovation. We will help our client build an integrated system that reflects the needs of an organization as complex as AIFA. In this task, we are helped by our significant experience in central and local health administrative processes, international best-practices and high performance in the public sector."
Accenture delivers decision support and analytic solutions for clinical care, health administration, finance and patient operations for leading public and private health institutions worldwide.
Accenture is a global management consulting, technology services and outsourcing company with over 257,000 people serving clients in more than 120 countries. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world's most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments. The company generated net revenues of US$27.9 billion for the fiscal year ended Aug. 31, 2012. Its home page is www.accenture.com.
KEYWORDS: United States Europe North America New York Italy
The article Accenture Awarded Three-Year Contract by Italian Medicines Agency for Implementation and Maintenance of Medicines' Evaluation Systems in Italy originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.